Denali Advisors’s Evolent Health EVH Stock Holding History

Denali Advisors’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-78	Closed	-$2.56K	–	273
2024 Q1	$2.56K	Buy	+78	New	+$2.49K	﹤0.01%	392

Other funds holding EVH

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Denali Advisors's EVH Position: Q2 2024 in Review

Denali Advisors sold out of Evolent Health (EVH) in Q2 2024, closing a stake of 78 shares — an estimated $2.56K sold.

Denali Advisors first reported a position in EVH in Q1 2024 and held it in 1 quarter. The position peaked at $2.56K in Q1 2024. 243 funds tracked by Wall St. Rank hold EVH as of Q2 2024.

Denali Advisors reported no remaining Evolent Health position as of Q2 2024 after selling out during the quarter.
Denali Advisors sold 78 Evolent Health shares in Q2 2024, an estimated $2.56K.
Denali Advisors first reported a position in Evolent Health in Q1 2024 and held it in 1 quarter.
Denali Advisors's Evolent Health position peaked at $2.56K in Q1 2024.
243 funds tracked by Wall St. Rank held Evolent Health as of Q2 2024.

Based on Denali Advisors's 13F filing for Q2 2024, filed 9 Aug 2024.